PDCD1 and soft tissue sarcoma: There are several latest researches suggesting B cells-originated involvement in the immune response and that B cell enrichment was considered as the most convincing prognostic indicator and positively associated with the response to PD-1 blockade in soft-tissue sarcomas [47–51].